Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma × Surgical Procedures, Operative × Clear all

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Rectal Neoplasms 3 Stomach Neoplasms 2 Colorectal Neoplasms 2 Skin Neoplasms 1 Radiation Injuries 1 Postoperative Complications 1 Pilonidal Sinus 1 Neoplasms 1 Low Anterior Resection Syndrome 1 Gestational Trophoblastic Disease 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 3 Cisplatin 3 Radiotherapy 2 Radiation 2 Platinum 2 Magnetic Resonance Spectroscopy 2 Immunoglobulin G 2 Disulfides 2 Cetuximab 2 1,2-diaminocyclohexaneplatinum II citrate 2 (225)Ac-DOTA-c(RGDyK) 2 durvalumab 1 atezolizumab 1 Surgical Procedures, Operative 1 Specimen Handling 1 Photochemotherapy 1 Neck Dissection 1 Irinotecan 1 Gemcitabine 1 Endoscopy 1 Docetaxel 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡